arcoris bio
Latest round
- Seed
Last raised
- Oct 2025
Total raised
- $7.9M
Investors
- 5
About arcoris bio
Based in Switzerland, arcoris bio AG specializes in advanced biomarker detection using innovative technologies for multiplex imaging of nucleic acids and proteins, serving research and clinical laboratories globally. Founded in 2022 in Schlieren, Switzerland, arcoris bio AG focuses on biomarker detection technology. Arcoris Bio specializes in advanced biomarker detection through its proprietary MUSE® technology, which employs self-assembling, enzyme-free DNA nanotechnology for multiplex imaging of nucleic acids and proteins. The platform enables simultaneous detection of proteins, DNA, and RNA, facilitating applications such as immunofluorescence and in situ hybridization. Key users include researchers and laboratories in molecular biology and histology, benefiting from the technology’s capacity to handle multiple labels. Arcoris Bio primarily targets markets in Europe, North America, and Asia, providing solutions to academic institutions, clinical laboratories, and biotechnology companies. Arcoris Bio generates revenue through the sale of its MUSE® kits and custom solutions to B2B clients, including research institutions and laboratories. Their flagship products, such as the immunoMUSE and rnaMUSE kits, cater to clients involved in biomarker analysis, with pricing structured for bulk purchases. Partnerships for white-label solutions further enhance revenue potential, allowing tailored applications of MUSE® technology.
Who invested in arcoris bio
5 investors across 1 round
See all investors in arcoris bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Oct 7, 2025
Amount
$7.9M
Investors
Questions about arcoris bio
Who invested in arcoris bio?
arcoris bio has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has arcoris bio raised?
arcoris bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did arcoris bio last raise money?
arcoris bio's most recent round on record is a Seed, in Oct 2025.
What does arcoris bio do?
Based in Switzerland, arcoris bio AG specializes in advanced biomarker detection using innovative technologies for multiplex imaging of nucleic acids and proteins, serving research and clinical laboratories globally.
Where is arcoris bio headquartered?
arcoris bio is headquartered in Schlieren, Switzerland.
Which VCs invest in companies like arcoris bio?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at arcoris bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like arcoris bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.